SB 203580, p38 MAP kinase inhibitor, 5mg, CAS# 152121-47-6

SB 203580, p38 MAP kinase inhibitor, 5mg, CAS# 152121-47-6

Tofacitinib, JAK inhibitor, 5mg, CAS# 477600-75-2

Tofacitinib, JAK inhibitor, 5mg, CAS# 477600-75-2

Sorafenib_base, Raf-1 inhibitor (and other kinases), 50mg, CAS# 284461-73-0

$160.00
4-(4-(3-(4-chloro-3-(trifluoromethyl)phenyl)ureido)phenoxy)-N-methylpicolinamide Purity: 99% by TLC Purity: NMR (Conforms) Store -20°C Ship RT (1 per EA )

Manufacturer: Focus Biomolecules

SKU
10-2174-50mg-EA
Sorafenib_base, Raf-1 inhibitor (and other kinases), 50mg, CAS# 284461-73-0 is available to buy in increments of 1

Product Details

Download Details and Specifications

Initially developed as a Raf kinase inhibitor, IC50 = 6 nM, but has been shown to inhibit many receptor tyrosine kinases including BRAF (IC50 = 22 nM); VEGFR-2 (IC50 = 90 nM); VEGFR-3 (IC50 = 20 nM); PDGFR-β (IC50 = 57 nM); Flt3 (IC50 = 58 nM); c-KIT (IC50 = 68 nM); FGFR-1 (IC50 = 580 nM)1. Paradoxically more potent in a cellular assay (IC50 = 20 nM) compared to an isolated enzyme assay (IC50 = 107 nM) for c-Fms2. Inhibits activation of MAPK pathway and ERK phosphorylation3. Induces caspase-independent apoptosis in melanoma cells4. Clinically useful anticancer agent.

CAS Number: 284461-73-0

Manufacturer Part Number/SKU: 10-2174-50mg-EA

Tags: Focus Biomolecules